Uwe Nicolay
GlaxoSmithKline (Belgium)(BE)
Publications by Year
Research Areas
Influenza Virus Research Studies, Immune Response and Inflammation, Respiratory viral infections research, Hematopoietic Stem Cell Transplantation, Vaccine Coverage and Hesitancy
Most-Cited Works
- → Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children(2011)331 cited
- → MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database(2009)183 cited
- → Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.(2000)148 cited
- → Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects(2014)137 cited
- → Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy(2011)92 cited
- → Influence of Statins on Influenza Vaccine Response in Elderly Individuals(2015)87 cited
- → GM-CSF in a Double-Blind Randomized Placebo-Controlled Trial in Therapy of Adult Patients with De Novo Acute Myeloid Leukemia(1994)84 cited
- → Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience(2019)47 cited
- → Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis(2010)41 cited
- → Trivalent and quadrivalent MF59®-adjuvanted influenza vaccine in young children: A dose- and schedule-finding study(2011)40 cited